Shaomin Tian

3.4k total citations · 1 hit paper
55 papers, 2.8k citations indexed

About

Shaomin Tian is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Shaomin Tian has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Molecular Biology and 12 papers in Biomedical Engineering. Recurrent topics in Shaomin Tian's work include Immunotherapy and Immune Responses (13 papers), Nanoparticle-Based Drug Delivery (10 papers) and Mosquito-borne diseases and control (8 papers). Shaomin Tian is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Nanoparticle-Based Drug Delivery (10 papers) and Mosquito-borne diseases and control (8 papers). Shaomin Tian collaborates with scholars based in United States, China and France. Shaomin Tian's co-authors include Joseph M. DeSimone, Mary E. Napier, J. Christopher Luft, Jillian L. Perry, Jin Wang, Robby A. Petros, Joseph M. DeSimone, Yuanzeng Min, Benjamin G. Vincent and Laura E. Herring and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Shaomin Tian

52 papers receiving 2.8k citations

Hit Papers

Antigen-capturing nanoparticles improve the abscopal effe... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Shaomin Tian
Lukasz J. Ochyl United States
Conlin P. O’Neil Switzerland
Ankur Singh United States
Eric M. Bachelder United States
Ana Jaklenec United States
Lukasz J. Ochyl United States
Shaomin Tian
Citations per year, relative to Shaomin Tian Shaomin Tian (= 1×) peers Lukasz J. Ochyl

Countries citing papers authored by Shaomin Tian

Since Specialization
Citations

This map shows the geographic impact of Shaomin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaomin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaomin Tian more than expected).

Fields of papers citing papers by Shaomin Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaomin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaomin Tian. The network helps show where Shaomin Tian may publish in the future.

Co-authorship network of co-authors of Shaomin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Shaomin Tian. A scholar is included among the top collaborators of Shaomin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaomin Tian. Shaomin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phan, Thanh T.N., Wei‐Chiao Huang, Jonathan F. Lovell, et al.. (2025). Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference. npj Vaccines. 10(1). 119–119. 1 indexed citations
2.
Rajesh, Netra U., Yue Xu, Maria T. Dulay, et al.. (2025). Free‐Form Microfluidic Microneedle Array Patches. Advanced Functional Materials. 35(52).
3.
Tian, Shaomin, et al.. (2025). Leucophyllusins A–H: new abietane, pimarane, and ent-kaurane diterpenoids from Isodon leucophyllus. Fitoterapia. 184. 106656–106656.
4.
Pan, Wen, et al.. (2024). Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance. Advanced Functional Materials. 34(45). 4 indexed citations
5.
Rajesh, Netra U., Jihyun Hwang, Yue Xu, et al.. (2024). 3D‐Printed Latticed Microneedle Array Patches for Tunable and Versatile Intradermal Delivery. Advanced Materials. 36(44). e2404606–e2404606. 17 indexed citations
6.
Mao, Chengqiong, Stacy Yeh, Juan Fu, et al.. (2022). Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression. Science Translational Medicine. 14(648). eabh1261–eabh1261. 82 indexed citations
7.
Kudlacek, Stephan T., Stefan Metz, Thanh T.N. Phan, et al.. (2021). Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies. Science Advances. 7(42). eabg4084–eabg4084. 28 indexed citations
8.
Chiu, Norman H. L., Ziyu Yin, Xuewei Zhu, et al.. (2021). Modulation of Macrophage Polarization by Carbon Nanodots and Elucidation of Carbon Nanodot Uptake Routes in Macrophages. Nanomaterials. 11(5). 1116–1116. 9 indexed citations
9.
Mao, Chengqiong, Yan Zhao, Fang Li, et al.. (2018). P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. Journal of Controlled Release. 286. 289–300. 20 indexed citations
10.
Metz, Stefan, Xianwen Yi, Michael J. Miley, et al.. (2018). Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype. PLoS neglected tropical diseases. 12(9). e0006793–e0006793. 19 indexed citations
11.
Kapadia, Chintan H., et al.. (2017). Extending antigen release from particulate vaccines results in enhanced antitumor immune response. Journal of Controlled Release. 269. 393–404. 27 indexed citations
12.
Metz, Stefan, Shaomin Tian, Xianwen Yi, et al.. (2016). Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses. PLoS neglected tropical diseases. 10(10). e0005071–e0005071. 30 indexed citations
13.
Kapadia, Chintan H., Jillian L. Perry, Shaomin Tian, J. Christopher Luft, & Joseph M. DeSimone. (2015). Nanoparticulate immunotherapy for cancer. Journal of Controlled Release. 219. 167–180. 81 indexed citations
14.
Xu, Jing, J. Christopher Luft, Xianwen Yi, et al.. (2013). RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles. Molecular Pharmaceutics. 10(9). 3366–3374. 36 indexed citations
15.
Dunn, Stuart S., Shaomin Tian, Steven Blake, et al.. (2012). Reductively Responsive siRNA-Conjugated Hydrogel Nanoparticles for Gene Silencing. Journal of the American Chemical Society. 134(17). 7423–7430. 134 indexed citations
16.
Gratton, Stephanie E. A., Mary E. Napier, Patricia A. Ropp, Shaomin Tian, & Joseph M. DeSimone. (2008). Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles. Pharmaceutical Research. 25(12). 2845–2852. 79 indexed citations
17.
Tian, Shaomin, Robert Maile, Edward J. Collins, & Jeffrey A. Frelinger. (2007). CD8+ T Cell Activation Is Governed by TCR-Peptide/MHC Affinity, Not Dissociation Rate. The Journal of Immunology. 179(5). 2952–2960. 99 indexed citations
18.
Kumar, Santosh, Chang‐Zhi Dong, Navid Madani, et al.. (2006). SMM-Chemokines: A Class of Unnatural Synthetic Molecules as Chemical Probes of Chemokine Receptor Biology and Leads for Therapeutic Development. Chemistry & Biology. 13(1). 69–79. 25 indexed citations
19.
Tricerri, M. Alejandra, et al.. (2002). Folding and stability of the C-terminal half of apolipoprotein A-I examined with a Cys-specific fluorescence probe. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1594(2). 286–296. 23 indexed citations
20.
Tian, Shaomin & Ana Jonas. (2002). Structural and functional properties of apolipoprotein A-I mutants containing disulfide-linked cysteines at positions 124 or 232. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1599(1-2). 56–64. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026